| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 544 | 2021 |
| Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach TH Kim, IH Kim, SJ Kang, M Choi, BH Kim, BW Eom, BJ Kim, BH Min, ... Journal of gastric cancer 23 (1), 3, 2023 | 164 | 2023 |
| A Case of Hemolytic Uremic Syndrome Caused by Escherichia coli O104:H4 WK Bae, YK Lee, MS Cho, SK Ma, SW Kim, NH Kim, KC Choi Yonsei medical journal 47 (3), 437-439, 2006 | 137 | 2006 |
| Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer WK Bae, JE Hwang, HJ Shim, SH Cho, JK Lee, SC Lim, WK Chung, ... Cancer chemotherapy and pharmacology 65, 589-595, 2010 | 118 | 2010 |
| Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer JE Hwang, HN Kim, DE Kim, HJ Choi, SH Jung, HJ Shim, WK Bae, ... BMC cancer 11, 1-7, 2011 | 100 | 2011 |
| BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin HJ Shim, JY Yun, JE Hwang, WK Bae, SH Cho, JH Lee, HN Kim, MH Shin, ... Cancer science 101 (5), 1247-1254, 2010 | 94 | 2010 |
| Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer WK Bae, MS Park, JH Lee, JE Hwang, HJ Shim, SH Cho, DE Kim, HM Ko, ... Biomaterials 34 (4), 1433-1441, 2013 | 88 | 2013 |
| Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population JM Piao, MH Shin, SS Kweon, HN Kim, JS Choi, WK Bae, HJ Shim, ... World journal of gastroenterology: WJG 15 (45), 5716, 2009 | 87* | 2009 |
| Oral siRNA delivery to treat colorectal liver metastases SH Kang, V Revuri, SJ Lee, S Cho, IK Park, KJ Cho, WK Bae, Y Lee ACS nano 11 (10), 10417-10429, 2017 | 85 | 2017 |
| Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer JE Hwang, JY Hong, K Kim, SH Kim, WY Choi, MJ Kim, SH Jung, HJ Shim, ... BMC cancer 13, 1-8, 2013 | 79 | 2013 |
| Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy S Uthaman, S Pillarisetti, AP Mathew, Y Kim, WK Bae, KM Huh, IK Park Biomaterials 232, 119702, 2020 | 78 | 2020 |
| Does awareness of terminal status influence survival and quality of life in terminally ill cancer patients? SY Kim, JM Kim, SW Kim, IS Shin, KY Bae, HJ Shim, JE Hwang, WK Bae, ... Psycho‐Oncology 22 (10), 2206-2213, 2013 | 73 | 2013 |
| The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers WK Bae, KH Yoo, JS Lee, Y Kim, IJ Chung, MH Park, JH Yoon, PA Furth, ... Molecular carcinogenesis 54 (10), 1172-1180, 2015 | 68 | 2015 |
| Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells MK Baek, JS Park, JH Park, MH Kim, HD Kim, WK Bae, IJ Chung, BA Shin, ... Cancer letters 290 (1), 123-128, 2010 | 59 | 2010 |
| The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration WK Bae, K Kang, JH Yu, KH Yoo, VM Factor, K Kaji, M Matter, ... The FASEB Journal 29 (5), 1653, 2014 | 57 | 2014 |
| Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer JE Hwang, SH Kim, J Jin, JY Hong, MJ Kim, SH Jung, HJ Shim, W Bae, ... Clinical & experimental metastasis 31, 25-32, 2014 | 56 | 2014 |
| Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2 D Lau-Corona, WK Bae, L Hennighausen, DJ Waxman PLoS genetics 16 (5), e1008796, 2020 | 55 | 2020 |
| Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients MW Chung, MJ Kim, EJ Won, YJ Lee, YW Yun, SB Cho, YE Joo, ... World journal of gastroenterology 27 (42), 7340, 2021 | 54 | 2021 |
| Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer. T Powles, JE Gschwend, Y Loriot, J Bellmunt, L Geczi, C Vulsteke, ... Journal of Clinical Oncology 35 (15_suppl), TPS4590-TPS4590, 2017 | 52 | 2017 |
| Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy … JE Hwang, JY Hong, JE Kim, HJ Shim, WK Bae, EC Hwang, O Jeong, ... Japanese journal of clinical oncology 45 (6), 541-546, 2015 | 52 | 2015 |
